Blog

Regentis-Pharma received an Eurostars (European) funding for the development of a new medical device for the treatment of gum pathologies (inflammations, gingivitis, periodontitis…).

This project is established between several European entities, private and public, bringing together skills essential to the success of the project. The partners currently developing a unique medical device and promising results have been obtained on inflammation and tissue repair.

This project will lead to the development of a medical device for the treatment of inflamed gums.